Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Stocks To Watch: INFY, INTC, NHTC, NVDA

Published 10/01/2015, 12:30 AM
Updated 07/09/2023, 06:31 AM

The markets had a big rally on Wednesday, and it was a good day for Wall Street. The technicals were pretty good, too. So, we’re going to take a look at some stocks that snapped back, especially biotech’s and Chinese stocks, just to give you a sampling of what’s out there.

Infosys Limited (NYSE:INFY), a Indian technology company, had a great day on Wednesday, up 1.04 to 19.09, or 5.76%, on 10.5 million shares. It is in a large wedge pattern. It popped out of the wedge on Tuesday, and then exploded on Wednesday. The targets for this stock are now 20, 21, and 24 going forward.

Intel Corportation (NASDAQ:INTC) is really looking good. It’s in a nice, strong, 3-wave corrective pullback, with the forth wave forming. It jumped 90 cents to 30.14, or 3%, on 41 million shares. That’s the best volume on an up-day in about a month. It may follow through as early as Thursday. The declining topsline comes in around 32, so the next target is 31 1/4-1/2.

Natural Health Trend (NASDAQ:NHTC) is acting very well considering the market. On Wednesday, it popped 2.88 to 32.68, or nearly 10%, on 249,000. This stock pretty much backed off resistance to hold the moving averages down. It looks like it’s broken out, pulled back, retested, and may be on its way back up again. 28 1/2 will get this one out above resistance, and then 35 1/2, and 39 are the targets for NHTC.

NVIDIA Corporation (NASDAQ:NVDA) popped 94 cents to 24.65, or 4%, on nearly 14 million shares on Wednesday. The long-term channel goes back to 2012, taking this stock from the 11 range, all the way up to the 24 area. At this point, the top of the channel says 26 1/2 short-term, but it may see more than that.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Other stocks on the long side include Esperion Th (NASDAQ:ESPR), JinkoSolar Holding Company Limited (NYSE:JKS), Neurocrine Biosciences Inc (NASDAQ:NBIX), 58Com Inc Adr (NYSE:WUBA).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.